AbbVie, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical Research and Development
Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.
CEO Name:
Richard Gonzalez
Pharmaceutical Research and Development
Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.
CEO Name:
Richard Gonzalez
Contact
BS
Bria Scudder
1 NORTH WAUKEGAN ROAD, DEPT. V38L, BLDG. ABV-1
NORTH CHICAGO, IL 60064
224-257-6949
bria.scudder@abbvie.com
1 NORTH WAUKEGAN ROAD, DEPT. V38L, BLDG. ABV-1
NORTH CHICAGO, IL 60064
224-257-6949
bria.scudder@abbvie.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Christina Lechter | Exclusive Duties No | Authorized On 12/21/2020 | Withdrawn On 4/23/2021 |
| William J McCoshen | Exclusive Duties Yes | Authorized On 12/21/2020 | Withdrawn On N/A |
| Tony Langenohl | Exclusive Duties Yes | Authorized On 2/8/2021 | Withdrawn On N/A |
| Christina Lechter | Exclusive Duties No | Authorized On 8/13/2021 | Withdrawn On 8/8/2022 |
| Bria Scudder | Exclusive Duties No | Authorized On 8/9/2022 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 215
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services
Health Services: Medicaid Services
Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Insurance: Supervision of the Insurance Industry
Insurance: Supervision of the Insurance Industry
Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to drug affordability and accessibility
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to drug affordability and accessibility
Development, drafting or introduction of a proposal relating to drug affordability and accessibility
Action Intended To Affect
Legislative matter
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for
health coverage
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage
Action Intended To Affect
Legislative matter
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 January - June $29,175.00 |
2021 July - December $31,875.00 |
2022 January - June $43,800.00 |
2022 July - December $15,795.08 |
Total $120,645.08 |
| Total Hours Communicating | 2021 January - June 21.00 |
2021 July - December 52.00 |
2022 January - June 13.50 |
2022 July - December 18.00 |
Total 104.50 |
| Total Hours Other | 2021 January - June 53.00 |
2021 July - December 96.50 |
2022 January - June 24.00 |
2022 July - December 47.00 |
Total 220.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 36% |
2021 July - December 43% |
2022 January - June 66% |
2022 July - December 9% |
Total 38% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 36% |
2021 July - December 43% |
2022 January - June 26% |
2022 July - December 9% |
Total 33% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for
health coverage
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 28% |
2021 July - December 7% |
2022 January - June 8% |
2022 July - December 82% |
Total 27% |
Development, drafting or introduction of a proposal relating to drug affordability and accessibility
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 7% |
2022 January - June |
2022 July - December |
Total 3% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.